Extended Depth-Of-Focus Intraocular Lensimplantation In Patients With Age-Related Macular Degeneration: A Pilot Study
Published 2024 - 42nd Congress of the ESCRS
Reference: FP17.03 | Type: Free paper | DOI: 10.82333/k0gd-zz72
Authors: Akshaya Thananjeyan* 1 , Chandra Bala 2 , Angela Jennings 2 , Anna Siu 2
1Emergency Department,St Vincent's Hospital,Sydney,Australia, 2PersonalEYES,Sydney,Australia
Purpose
To assess visual outcomes of the implantation of a non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) in patients with age-related macular degeneration (AMD).
Setting
Single Private Practice
Methods
Patients with AMD undergoing cataract surgery and receiving non-diffractive EDOF AcrySof IQ Vivity IOL implantation over a 2-year period were identified. Corrected distance visual acuity (CDVA), distance-corrected near visual acuity (DCNVA; 50 cm), contrast sensitivity, central foveal thickness, VF-14 questionnaire results, and quality of life where available were analyzed.
Results
28 patients (51 eyes) were included (46% male, mean age 77.4 years). 27 eyes had late AMD, 17 (63%) had wet AMD. Mean preoperative CDVA was logMAR 0.32±0.29. Postoperative monocular CDVA and DCNVA were logMAR 0.20±0.25 and N9±5. Eyes achieving post op CDVA 6/5–6/12 (n=42, 82%), 6/15–6/24 (n=7, 14%), and greater than 6/24 (n=2, 4%) achieved a mean DCNVA of N8 , N13 and N27. Eyes achieving CDVA 6/5–6/12 had contrast sensitivity within normal. Patients with CDVA of Snellen 6/5–6/12 reported minimal visual impairment of VF-14 questionnaire, while patients with CDVA greater than 6/15 reported mild impairment. 96% (n=27) were satisfied with the improvement in quality of life postoperatively. No intraoperative complications were reported.
Conclusions
The EDOF AcrySof IQ Vivity IOL provides improved near vision proportional to distance vision in patients with early AMD